The company is committed to becoming a global API supplier of first aid rescue drugs and poison solutions.

Horvar Pharmaceutical was founded in 2007, located in Zhejiang Province chemical raw material drug base Linhai Park. The registered capital of the enterprise is 30 million yuan, the total investment is more than 200 million yuan, and the area is about 50 mu. The company is a comprehensive API manufacturing enterprise integrating research and development, production and sales, and in Sichuan and Guangzhou has a strategic cooperation research and development team with more than 500 people.

The company has a research and development center, a synthesis room, analysis room, and equipped with multi-functional production workshop. The company is also equipped with advanced liquid chromatograph, gas chromatograph and molecular weight tester and other instruments. New products are launched every year. Adhere to the "science and technology factory, quality factory" policy, aiming at the international market, relying on scientific and technological progress and technological innovation, the company actively develop high-tech products with colleges and universities and research and development institutions. After years of careful management, the enterprise carries out systematic, standardized, standardized and scientific management, and establishes a benign development platform. In order to adapt to the international and domestic market demand, improve the enterprise grade and economic benefits, Horvar Pharmaceutical with the existing research and development, management and marketing advantages, constantly pay attention to the development of the enterprise itself.

The company adheres to the concept of "people-oriented, common development" for employees, and insists on building the company as a platform for employees to make continuous progress and constantly output value for customers.